Join
Live feed
·
INSIDERFilingvia Quantisnow
BioCryst Pharmaceuticals Inc. logo

Chief R&D Officer Thackray Helen M. was granted 125,950 shares and covered exercise/tax liability with 6,096 shares, increasing direct ownership by 45% to 384,843 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BCRX (BioCryst Pharmaceuticals Inc.) and more on Quantisnow.

Chief R&D Officer Thackray Helen M. was granted 125,950 shares and covered exercise/tax liability with 6,096 shares, increasing direct ownership by 45% to 384,843 units (SEC Form 4) | Quantisnow